• Fonterra Co-operative Group CEO Miles Hurrell says higher margins and sales volumes in the co-op's Foodservice and Consumer channels, which helped offset lower returns in its Ingredients business, were behind its strong performance in FY24. 
    Fonterra Co-operative Group CEO Miles Hurrell says higher margins and sales volumes in the co-op's Foodservice and Consumer channels, which helped offset lower returns in its Ingredients business, were behind its strong performance in FY24. 
Close×

Fonterra has sold its Soprole dairy business to Gloria Foods for 591.07 billion Chilean Pesos (NZ$1.055 billion) just over a year since the company flagged it was looking to offload the business.

CEO Miles Hurrell said the co-op was working to differentiate New Zealand milk on the world stage and the Chilean operations didn’t require New Zealand-sourced milk or expertise.

It owned Sorpole and its subsidiary Prolesur, which source milk and manufacture dairy products in Southern Chile.

The divestment process began in April, culminating in the sale to Gloria Foods - JORB S.A., a consumer dairy market leader in Peru, with operations in Bolivia, Puerto Rico, Argentina, Colombia and Uruguay. 

Fonterra and Gloria Foods have a long-standing commercial relationship in South America.

The sale is subject to a number of conditions including regulatory approvals and an irrevocable public tender offer process in Chile for the outstanding shares in Soprole not already owned by Fonterra. Satisfaction of conditions is expected to take approximately six months.

Fonterra said its previously announced FY23 earnings guidance will continue to reflect only the underlying performance of the Soprole business during the pre-completion period. Fonterra will provide an update on the overall impact of its divestment programme as part of its FY23 financial reporting.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.